CADIAN CAPITAL MANAGEMENT, LP - INTERSECT ENT INC ownership

INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 161 filers reported holding INTERSECT ENT INC in Q2 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.

Quarter-by-quarter ownership
CADIAN CAPITAL MANAGEMENT, LP ownership history of INTERSECT ENT INC
ValueSharesWeighting
Q3 2018$9,617,000
-23.2%
334,5140.0%0.44%
-27.5%
Q2 2018$12,528,000
+26.1%
334,514
+32.3%
0.60%
+12.3%
Q1 2018$9,933,000
+267.9%
252,757
+110.6%
0.54%
+453.6%
Q4 2015$2,700,000
-3.8%
120,0000.0%0.10%
-4.0%
Q3 2015$2,808,000120,0000.10%
Other shareholders
INTERSECT ENT INC shareholders Q2 2018
NameSharesValueWeighting ↓
KOPP INVESTMENT ADVISORS LLC 186,561$5,364,0004.51%
First Light Asset Management, LLC 517,121$14,867,0002.40%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,147,950$61,754,0002.21%
HealthCor Management, L.P. 1,950,000$56,063,0001.86%
PURA VIDA INVESTMENTS, LLC 200,000$5,750,0001.21%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 112,000$2,469,0001.17%
Broadfin Capital, LLC 234,200$6,733,0000.99%
Lombard Odier Asset Management (USA) Corp 240,000$6,900,0000.51%
PURA VIDA INVESTMENTS, LLC 83,527$2,401,0000.50%
Rock Springs Capital Management LP 460,000$13,225,0000.48%
View complete list of INTERSECT ENT INC shareholders